CLINICAL ROLE -
First Oral Short-course Treatment Approved in Europe for Active Relapsing Multiple Sclerosis
Cladribine tablets demonstrated sustained clinical efficacy for up to 4 years treating multiple sclerosis.
Read More
Employing Artificial Intelligence to Detect Skin Cancer Earlier
Novel technology could reduce the number of unnecessary biopsies, ultimately reducing health care costs.
Hurricane Harvey Shows Why Specialty Pharmacies Matter During Natural Disasters
Houston-based specialty pharmacy takes extraordinary measures to demonstrate commitment to their patients during Hurricane Harvey.
PCSK9 Inhibitors May Harness Immune Mechanisms to Reduce Heart Disease Risks
PCSK9 inhibitors alter dendritic cells and T cells to reduce atherosclerosis.
Research Organization Collaborates with IBM to Identify Type 1 Diabetes Risks
JDRF and IBM partner to develop data-driven methods to predict the onset of type 1 diabetes.
IPhone App Heads Large-Scale Research Study in Multiple Sclerosis
Newly launched mobile research study uses real-time data collection in MS.
Acupressure Combats Fatigue in Breast Cancer Survivors
Self-administered acupressure found to improve sleep and daytime alertness among breast cancer survivors.
Trending News Today: Funding Cut for ACA Advertisement, Insurance Navigation
Top news of the day from across the healthcare landscape.
Trending News Today: Delaying Treatment for Thyroid Cancer Can be Safe
Pharmacy Week in Review: September 1, 2017
A look at the top stories in pharmacy last week.
Watch
Injectable Antibiotic Recalled Due to Glass in the Vial
Hospira recalls vancomycin hydrochloride injection due to particulate matter contamination.
FDA Continues to Monitor Keytruda Clinical Trial Hold
Clinical trial holds were placed on pembrolizumab to treat multiple myeloma following adverse event concerns.
FDA Issues Statement on Keytruda Clinical Trial Holds
Pembrolizumab (Keytruda) combination therapy may increase mortality risk among multiple myeloma patients.
Biosimilar, Gene Therapy Approval Top SPT Week in Review
Top articles of the week from Specialty Pharmacy Times.
Integrated Care Improves Hepatitis C Treatment of Hard-to-Reach Patients
Patients with psychological and substance use problems are less likely to stay engaged in hepatitis C care.
Improvements Needed in HPV Vaccinations Among Adolescents
Human papillomavirus vaccine rates are on the rise among US teens but more work is needed.
CDC Urges Health Care Providers to Educate About Sepsis
This initiative emphasizes the importance of early recognition and timely treatment of sepsis, as well as the importance of preventing infections that could lead to sepsis.
More Adolescents Receiving HPV Vaccine, But Need for Improvement Remains
Human papillomavirus (HPV) vaccine rates are on the rise among US teens but more work is needed to get more teens vaccinated.
5 Steps to Stay Motivated Every Day
Imagine a sense of motivation so great, so powerful, that you literally cannot wait to start your day.
Pharmacists in Texas Provide Calm Amidst the Storm of Hurricane Harvey
Texas-based pharmacies work to ensure access to lifesaving medications for patients displaced and homeless due to the flooding caused by Hurricane Harvey.
Vitamin C Deters Proliferation of Leukemia Stem Cells
High-dose vitamin C found to revert leukemia stem cells with a specific mutation back to normal cells.
Young Adults Not Achieving Adequate Blood Pressure Control
Younger men are less likely to be aware of and receive treatment for hypertension.
Sensory Neuron Discovery Could Lead to Novel Pain Treatments
A new class of neurons expand the knowledge of pain prevention.
Online Support Helps Parents of Children with Cancer Cope with Depression
Communicating with a psychologist via email improved stress and depression symptoms among parents of children with cancer.
Scientists Peel Back Mechanisms of Tumor-Infiltrating Immune Cells in Triple-Negative Breast Cancer Subtype
The findings highlight the role of Tregs in suppressing the immune response.
Hormonal Contraception May Reduce Rheumatoid Arthritis Risk
Seven or more years of oral contraceptive use was linked to a 19% reduced risk of rheumatoid arthritis.
Enzyme Target Shows Promise as Pancreatic Cancer Therapy
Targeting the arginase 2 enzyme observed to reduce the growth of pancreatic cancer.
Subcutaneous Implantation of Pancreatic Cells Shows Promise in Type 1 Diabetes
Pancreatic islet cells implanted under the skin may normalize blood glucose levels in type 1 diabetes patients.
Trending News Today: Bundled Payments Show Promise to Lower Healthcare Costs